What is Exploramed?
ExploraMed operates as a dedicated medical device incubator, focusing on the development of patient-centric solutions designed to address persistent medical challenges. The company's core mission is to enhance patient quality of life through the creation of innovative, cost-effective device technologies. To date, ExploraMed has successfully launched eight distinct companies, supported by four previous funding rounds and strategic alliances with prominent entities within the medical technology landscape. The incubator is committed to challenging conventional approaches while maintaining a steadfast focus on patient needs.
How much funding has Exploramed raised?
Exploramed has raised a total of $47.5M across 3 funding rounds:
Private Equity
$18.5M
Private Equity
$14M
Private Equity
$15M
Private Equity (2008): $18.5M with participation from NEA and Morgenthaler Partners
Private Equity (2014): $14M led by New Enterprise Associates
Private Equity (2015): $15M supported by NEA
Key Investors in Exploramed
NEA
NEA (New Enterprise Associates) is a prominent venture capital firm with a broad investment focus, known for backing companies across various stages and sectors, including technology and healthcare.
New Enterprise Associates
New Enterprise Associates (NEA), established in 1977, is a venture capital firm that supports entrepreneurs in building businesses, with a significant presence in the technology and life sciences sectors.
Morgenthaler Partners
Morgenthaler Partners is a venture capital and private equity firm with extensive experience in fostering company growth, specializing in information technology and life sciences investments.
What's next for Exploramed?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for ExploraMed. This capital infusion is expected to accelerate the development and commercialization of its pipeline of patient-driven medical devices. The company's strategy likely involves expanding its incubation capabilities, forging new partnerships, and scaling its portfolio companies to address unmet medical needs more broadly. Continued investment in cutting-edge technology and a patient-first approach will be critical for ExploraMed's sustained success and market leadership in the medical device industry.
See full Exploramed company page
